Aurora Cannabis Q3 EPS Estimate Lowered by Atb Cap Markets

Aurora Cannabis Inc. (TSE:ACB) – Stock analysts at Atb Cap Markets cut their Q3 2025 earnings per share estimates for Aurora Cannabis in a research report issued to clients and investors on Monday, December 16th. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.18) per share for the quarter, down from their previous estimate of ($0.13). The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.22) per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ Q4 2025 earnings at ($0.14) EPS, FY2025 earnings at ($0.14) EPS, FY2026 earnings at ($0.23) EPS, FY2027 earnings at ($0.02) EPS and FY2029 earnings at $0.56 EPS.

Several other research firms have also recently commented on ACB. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. ATB Capital reduced their price objective on Aurora Cannabis from C$11.00 to C$8.50 in a research note on Tuesday. Three analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of C$5.85.

Aurora Cannabis Price Performance

ACB opened at C$5.88 on Thursday. Aurora Cannabis has a 1 year low of C$3.84 and a 1 year high of C$12.85. The company has a debt-to-equity ratio of 16.95, a current ratio of 3.76 and a quick ratio of 2.48. The firm’s fifty day moving average price is C$6.89 and its two-hundred day moving average price is C$7.56. The company has a market capitalization of C$321.40 million, a price-to-earnings ratio of -9.33 and a beta of 2.71.

Insider Buying and Selling

In other Aurora Cannabis news, Senior Officer Andre Jerome sold 7,712 shares of the stock in a transaction dated Monday, September 23rd. The shares were sold at an average price of C$7.70, for a total transaction of C$59,382.40.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.